{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T22:31:42Z","timestamp":1774650702018,"version":"3.50.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.canlet.2012.01.014","type":"journal-article","created":{"date-parts":[[2012,1,18]],"date-time":"2012-01-18T17:13:48Z","timestamp":1326906828000},"page":"120-127","source":"Crossref","is-referenced-by-count":64,"title":["Epidermal growth factor receptor-targeted photosensitizer selectively inhibits EGFR signaling and induces targeted phototoxicity in ovarian cancer cells"],"prefix":"10.1016","volume":"321","author":[{"given":"Adnan O.","family":"Abu-Yousif","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne C.E.","family":"Moor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark D.","family":"Savellano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiping","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e5l K.","family":"Selbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tayyaba","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2012.01.014_b0005","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canlet.2012.01.014_b0010","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.pdpdt.2009.05.001","article-title":"Cholangiocarcinoma: an emerging indication for photodynamic therapy","volume":"6","author":"Allison","year":"2009","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"10.1016\/j.canlet.2012.01.014_b0015","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/mpa.0b013e3180439c50","article-title":"Photodynamic therapy for pancreatic cancer","volume":"34","author":"Fan","year":"2007","journal-title":"Pancreas"},{"key":"10.1016\/j.canlet.2012.01.014_b0020","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/lsm.20444","article-title":"Incorporation of photodynamic therapy as an induction modality in non-small cell lung cancer","volume":"38","author":"Ross","year":"2006","journal-title":"Lasers Surg. Med."},{"key":"10.1016\/j.canlet.2012.01.014_b0025","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/978-1-60761-697-9_18","article-title":"Photodynamic therapy of head and neck cancers","volume":"635","author":"Biel","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.canlet.2012.01.014_b0030","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.2741\/3520","article-title":"Molecular mechanisms of photodynamic therapy","volume":"14","author":"Ortel","year":"2009","journal-title":"Front Biosci."},{"key":"10.1016\/j.canlet.2012.01.014_b0035","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1093\/jnci\/91.18.1557","article-title":"Combination photoimmunotherapy and cisplatin: effects on human ovarian cancer ex vivo","volume":"91","author":"Duska","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2012.01.014_b0040","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.mla.2006.05.006","article-title":"Death pathways associated with photodynamic therapy","volume":"21","author":"Kessel","year":"2006","journal-title":"Med. Laser Appl."},{"key":"10.1016\/j.canlet.2012.01.014_b0045","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1751-1097.2007.00267.x","article-title":"Promotion of PDT efficacy by a Bcl-2 antagonist","volume":"84","author":"Kessel","year":"2008","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.canlet.2012.01.014_b0050","series-title":"Photodynamic Therapy of Cancer","author":"Hasan","year":"2006"},{"key":"10.1016\/j.canlet.2012.01.014_b0055","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1158\/1078-0432.CCR-05-1625","article-title":"A phase II trial of intraperitoneal photodynamic therapy for patients with peritoneal carcinomatosis and sarcomatosis","volume":"12","author":"Hahn","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2012.01.014_b0060","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10434-001-0065-x","article-title":"Phase II trial of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors","volume":"8","author":"Hendren","year":"2001","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.canlet.2012.01.014_b0065","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0360-3016(93)90066-5","article-title":"Phase I study of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors","volume":"25","author":"DeLaney","year":"1993","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canlet.2012.01.014_b0070","first-page":"711","article-title":"Patterns of recurrence in patients treated with photodynamic therapy for intraperitoneal carcinomatosis and sarcomatosis","volume":"24","author":"Wilson","year":"2004","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2012.01.014_b0075","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1053\/j.seminoncol.2006.04.003","article-title":"Epidermal growth factor receptor targeting in cancer","volume":"33","author":"Mendelsohn","year":"2006","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.canlet.2012.01.014_b0080","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ctrv.2009.02.001","article-title":"Anti-epidermal growth factor receptor monoclonal antibodies in cancer treatment","volume":"35","author":"Capdevila","year":"2009","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.canlet.2012.01.014_b0085","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s10103-010-0790-0","article-title":"The role of epidermal growth factor receptor in photodynamic therapy: a review of the literature and proposal for future investigation","volume":"25","author":"Martinez-Carpio","year":"2010","journal-title":"Lasers Med. Sci."},{"key":"10.1016\/j.canlet.2012.01.014_b0090","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1093\/jnci\/dji314","article-title":"Synergism of epidermal growth factor receptor-targeted immunotherapy with photodynamic treatment of ovarian cancer in vivo","volume":"97","author":"del Carmen","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2012.01.014_b0095","unstructured":"R. Lewis, L. Schuman, M. Mickler, A. Durham, S. Evans, E. Glatstein, S. Hahn, D. Fraker, K. Cengel, Preclinical evaluation of cetuximab and benzoporphyrin derivative-mediated intraperitoneal photodynamic therapy in a canine model, in: 35th American Society for Photobiology Providence, RI, 2010."},{"key":"10.1016\/j.canlet.2012.01.014_b0100","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1562\/0031-8655(2003)077<0431:TCTOTE>2.0.CO;2","article-title":"Targeting cells that overexpress the epidermal growth factor receptor with polyethylene glycolated BPD verteporfin photosensitizer immunoconjugates","volume":"77","author":"Savellano","year":"2003","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.canlet.2012.01.014_b0105","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1158\/1078-0432.CCR-04-1902","article-title":"Photochemical targeting of epidermal growth factor receptor: a mechanistic study","volume":"11","author":"Savellano","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2012.01.014_b0110","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.4049\/jimmunol.130.3.1473","article-title":"Photoimmunotherapy: treatment of animal tumors with tumor-specific monoclonal antibody\u2013hematoporphyrin conjugates","volume":"130","author":"Mew","year":"1983","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2012.01.014_b0115","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/bjc.1997.149","article-title":"Biodistribution of charged F(ab\u2019)2 photoimmunoconjugates in a xenograft model of ovarian cancer","volume":"75","author":"Duska","year":"1997","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2012.01.014_b0120","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1196\/annals.1338.035","article-title":"Mitochondrion-targeted photosensitizer enhances the photodynamic effect-induced mitochondrial dysfunction and apoptosis","volume":"1042","author":"Peng","year":"2005","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.canlet.2012.01.014_b0125","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1073\/pnas.83.11.3825","article-title":"Monoclonal antibody against epidermal growth factor receptor is internalized without stimulating receptor phosphorylation","volume":"83","author":"Sunada","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2012.01.014_b0130","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0022-1759(00)00340-9","article-title":"Selection of cell binding and internalizing epidermal growth factor receptor antibodies from a phage display library","volume":"248","author":"Heitner","year":"2001","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.canlet.2012.01.014_b0135","first-page":"717","article-title":"A photobiological and photophysical-based study of phototoxicity of two chlorins","volume":"61","author":"Pogue","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2012.01.014_b0140","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/sj.bjc.6690448","article-title":"BPD-MA-mediated photosensitization in vitro and in vivo: cellular adhesion and beta1 integrin expression in ovarian cancer cells","volume":"80","author":"Runnels","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2012.01.014_b0145","doi-asserted-by":"crossref","first-page":"6371","DOI":"10.1158\/0008-5472.CAN-05-0426","article-title":"Multiepitope HER2 targeting enhances photoimmunotherapy of HER2-overexpressing cancer cells with pyropheophorbide-A immunoconjugates","volume":"65","author":"Savellano","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2012.01.014_b0150","first-page":"4762","article-title":"Photoimmunotherapy of human ovarian carcinoma cells ex vivo","volume":"51","author":"Goff","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2012.01.014_b0155","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/bjc.1994.330","article-title":"Photoimmunotherapy and biodistribution with an OC125-chlorin immunoconjugate in an in vivo murine ovarian cancer model","volume":"70","author":"Goff","year":"1994","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2012.01.014_b0160","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/nbt1137","article-title":"Monoclonal antibody therapy of cancer","volume":"23","author":"Adams","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.canlet.2012.01.014_b0165","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000259615","article-title":"Cetuximab-based treatment of metastatic anal cancer: correlation of response with KRAS mutational status","volume":"77","author":"Lukan","year":"2009","journal-title":"Oncology"},{"key":"10.1016\/j.canlet.2012.01.014_b0170","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/nrclinonc.2009.40","article-title":"Molecular therapy in head and neck oncology","volume":"6","author":"Bernier","year":"2009","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2012.01.014_b0175","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1056\/NEJMoa033025","article-title":"Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer","volume":"351","author":"Cunningham","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2012.01.014_b0180","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJMoa0802656","article-title":"Platinum-based chemotherapy plus cetuximab in head and neck cancer","volume":"359","author":"Vermorken","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2012.01.014_b0185","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/jcb.22366","article-title":"Targeted inhibition of the EGFR pathways enhances Zn-BC-AM PDT-induced apoptosis in well-differentiated nasopharyngeal carcinoma cells","volume":"108","author":"Koon","year":"2009","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.canlet.2012.01.014_b0190","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1476-4598-8-94","article-title":"Targeting EGFR with photodynamic therapy in combination with Erbitux enhances in vivo bladder tumor response","volume":"8","author":"Bhuvaneswari","year":"2009","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2012.01.014_b0195","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.addr.2003.09.003","article-title":"Photosensitizer-antibody conjugates for detection and therapy of cancer","volume":"56","author":"van Dongen","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.canlet.2012.01.014_b0200","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1104819","article-title":"Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy","volume":"307","author":"Jain","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.canlet.2012.01.014_b0205","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1562\/0031-8655(2000)071<0196:DOTART>2.0.CO;2","article-title":"Determinants of the apoptotic response to lysosomal photodamage","volume":"71","author":"Kessel","year":"2000","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.canlet.2012.01.014_b0210","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1751-1097.1997.tb08578.x","article-title":"Lysosomes and microtubules as targets for photochemotherapy of cancer","volume":"65","author":"Berg","year":"1997","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.canlet.2012.01.014_b0215","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1007\/s000180050369","article-title":"The stress-activated protein kinase pathways","volume":"55","author":"Tibbles","year":"1999","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.canlet.2012.01.014_b0220","doi-asserted-by":"crossref","first-page":"22033","DOI":"10.1074\/jbc.274.31.22033","article-title":"Multiple ras effector pathways contribute to G(1) cell cycle progression","volume":"274","author":"Gille","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2012.01.014_b0225","doi-asserted-by":"crossref","first-page":"27595","DOI":"10.1016\/S0021-9258(18)47026-3","article-title":"Antibody-induced epidermal growth factor receptor dimerization mediates inhibition of autocrine proliferation of A431 squamous carcinoma cells","volume":"269","author":"Fan","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2012.01.014_b0230","first-page":"3666","article-title":"Anti-epidermal growth factor receptor monoclonal antibody 225 up-regulates p27KIP1 and induces G1 arrest in prostatic cancer cell line DU145","volume":"56","author":"Peng","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2012.01.014_b0235","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1126\/science.286.5443.1358","article-title":"Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms","volume":"286","author":"Bonni","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.canlet.2012.01.014_b0240","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/excr.2000.4836","article-title":"Serine\/threonine protein kinases and apoptosis","volume":"256","author":"Cross","year":"2000","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.canlet.2012.01.014_b0245","first-page":"5988","article-title":"Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin","volume":"60","author":"Hayakawa","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2012.01.014_b0250","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1038\/sj.onc.1204313","article-title":"In vitro and in vivo inhibition of epidermal growth factor receptor-tyrosine kinase pathway by photodynamic therapy","volume":"20","author":"Ahmad","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2012.01.014_b0255","first-page":"4200","article-title":"Experimental photoimmunotherapy of hepatic metastases of colorectal cancer with a 17.1A chlorin(e6) immunoconjugate","volume":"60","author":"Del Governatore","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2012.01.014_b0260","doi-asserted-by":"crossref","first-page":"9221","DOI":"10.1073\/pnas.0904140106","article-title":"Targeting cancer cells by using an antireceptor antibody-photosensitizer fusion protein","volume":"106","author":"Serebrovskaya","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2012.01.014_b0265","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/ijc.23206","article-title":"Targeted photodynamic therapy with multiply-loaded recombinant antibody fragments","volume":"122","author":"Bhatti","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2012.01.014_b0270","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/1097-0215(20001001)88:1<108::AID-IJC17>3.0.CO;2-H","article-title":"Targeting of a hydrophilic photosensitizer by use of internalizing monoclonal antibodies: a new possibility for use in photodynamic therapy","volume":"88","author":"Vrouenraets","year":"2000","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2012.01.014_b0275","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1038\/sj.bjc.6605436","article-title":"In vivo high-resolution fluorescence microendoscopy for ovarian cancer detection and treatment monitoring","volume":"101","author":"Zhong","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2012.01.014_b0280","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s12094-008-0172-2","article-title":"Photodynamic therapy of cancer. Basic principles and applications","volume":"10","author":"Juarranz","year":"2008","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.canlet.2012.01.014_b0285","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/lsm.20507","article-title":"Interstitial photodynamic therapy of nonresectable malignant glioma recurrences using 5-aminolevulinic acid induced protoporphyrin IX","volume":"39","author":"Beck","year":"2007","journal-title":"Lasers Surg. Med."},{"key":"10.1016\/j.canlet.2012.01.014_b0290","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1615\/JEnvironPatholToxicolOncol.v26.i2.110","article-title":"ALA and malignant glioma: fluorescence-guided resection and photodynamic treatment","volume":"26","author":"Stepp","year":"2007","journal-title":"J. Environ. Pathol. Toxicol. Oncol."},{"key":"10.1016\/j.canlet.2012.01.014_b0295","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1562\/0031-8655(2003)077<0431:TCTOTE>2.0.CO;2","article-title":"Targeting cells that overexpress the epidermal growth factor receptor with polyethylene glycolated BPD verteporfin photosensitizer immunoconjugates","volume":"77","author":"Savellano","year":"2003","journal-title":"Photochem. Photobiol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383512000444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383512000444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T19:09:32Z","timestamp":1686683372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383512000444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0304383512000444"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2012.01.014","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}